An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children

Tanvir Huda, Harish Nair, Evropi Theodoratou, Lina Zgaga, Ali Fattom, Shams El Arifeen, Craig Rubens, Harry Campbell, Igor Rudan

Research output: Contribution to journalArticlepeer-review

Abstract

Staphylococcus aureus is a commensal of human skin and nares. It is also one of the leading nosocomial pathogens in both developed and developing countries and is responsible for a wide range of life threatening infections, especially in patients who are immunocompromised, post-surgery, undergoing haemodialysis and those who are treated with catheters and ventilators. Over the past two decades, the incidence of nosocomial staphylococcal infections has increased dramatically. Currently there are at least seven vaccine and immunotherapy candidates against S. aureus in the developmental phase targeting both active and passive immunization.
Original languageEnglish
Pages (from-to)S27
JournalBMC Public Health
Volume11 Suppl 3
DOIs
Publication statusPublished - 2011

Fingerprint Dive into the research topics of 'An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children'. Together they form a unique fingerprint.

Cite this